Company Filing History:
Years Active: 2002
Title: Eric W P Damen: Innovator in Antitumor Drug Development
Introduction
Eric W P Damen is a notable inventor based in Nijmegen, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of water-soluble analogs of paclitaxel, a well-known antitumor agent. His innovative work has the potential to enhance the efficacy and delivery of cancer treatments.
Latest Patents
Eric W P Damen holds a patent for "Water soluble analogs and prodrugs of paclitaxel." This invention relates to water-soluble antitumor analogs of paclitaxel, characterized by specific chemical formulas. The patent outlines the formulation of these analogs, which include various pharmaceutically acceptable counterions, and emphasizes their effectiveness as active ingredients in pharmaceutical compositions.
Career Highlights
Eric is associated with Pharmachemie B.V., where he continues to advance his research and development efforts. His work focuses on creating innovative solutions for cancer treatment, contributing to the ongoing fight against this disease.
Collaborations
Throughout his career, Eric has collaborated with esteemed colleagues such as Peter H G Wiegerinck and Duncan Sperling. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Eric W P Damen's contributions to the field of pharmaceuticals, particularly in the development of water-soluble analogs of paclitaxel, highlight his role as an innovator in antitumor drug development. His work not only showcases his expertise but also holds promise for improving cancer treatment options.